Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Recommendation of “Buy” from Brokerages

Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) have been given an average recommendation of “Buy” by the seven analysts that are currently covering the company, MarketBeat reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price […]

Leave a Reply

Your email address will not be published.

Previous post Viavi Solutions (NASDAQ:VIAV) Lowered to “Hold” Rating by StockNews.com
Next post Head-To-Head Contrast: Driven Brands (NASDAQ:DRVN) vs. Autozi Internet Technology (Global) (NASDAQ:AZI)